APA (7th ed.) Citation

T, J., D, Z., A, Z., IV, K., O, S., O, V., . . . R, H. (2026). Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs. Blood, 147(10), 1070. https://doi.org/10.1182/blood.2025029572

Chicago Style (17th ed.) Citation

T, Jelinek, et al. "Selective B-cell Subset Depletion Underlies Increased Infection Risk in Patients with MM Treated with Anti-BCMA Vs Anti-GPRC5D BsAbs." Blood 147, no. 10 (2026): 1070. https://doi.org/10.1182/blood.2025029572.

MLA (9th ed.) Citation

T, Jelinek, et al. "Selective B-cell Subset Depletion Underlies Increased Infection Risk in Patients with MM Treated with Anti-BCMA Vs Anti-GPRC5D BsAbs." Blood, vol. 147, no. 10, 2026, p. 1070, https://doi.org/10.1182/blood.2025029572.